Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...

Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments ...

A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.

Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...